4//SEC Filing
AMICUS THERAPEUTICS INC 4
Accession 0001209191-16-089821
$FOLDCIK 0001178879operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:18 PM ET
Size
11.1 KB
Accession
0001209191-16-089821
Insider Transaction Report
Form 4
Peist Kenneth
VP, Intellectual Property
Transactions
- Exercise/Conversion
Common stock
2016-01-04+25,000→ 28,187 total - Award
Stock Options (right to buy)
2016-01-04+45,000→ 45,000 totalExercise: $9.03Exp: 2026-01-04→ Common Stock (45,000 underlying) - Tax Payment
Common stock
2016-01-04$9.03/sh−9,313$84,096→ 18,874 total - Exercise/Conversion
Restricted stock units
2016-01-04−25,000→ 0 total→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On April 10, 2014, the reporting person was granted 50,000 restricted stock units, vesting in equal installments of 25,000 restricted stock units on May 10, 2015 and 25,000 restricted stock units on December 3, 2015.
- [F3]These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on January 4, 2017. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on February 1, 2017, with the final installment vesting on January 1, 2020.
Documents
Issuer
AMICUS THERAPEUTICS INC
CIK 0001178879
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001178879
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:18 PM ET
- Size
- 11.1 KB